Effective the 2023-2024 application cycle, the UCI PharmD program consolidated the UCI Graduate Division Supplemental Application into our program PharmCAS custom questions. We are enthusiastic this change will streamline the process for our applicants.
1) Complete PharmCAS application (by May 1, 2024):
- Complete PharmCAS application *early application is encouraged for rolling admissions
- Priority Deadline: December 1, 2023
- Applicants who apply by our priority deadline are eligible for the application reimbursement for the UCI Graduate Division supplemental fee post-matriculation into the PharmD program.
- Application Deadline: May 1, 2024
- Priority Deadline: December 1, 2023
2) Application Fees
- PharmCAS application fee
- UCI Graduate Division supplemental application fee
- Accessible starting October 2, 2023
- Details coming this fall
- UCI Graduate Division supplemental application fee
Fee Waiver
UCI Graduate Division offers application fee waivers to eligible applicants. Visit UCI Graduate Division – Application Fee to learn more about eligibility criteria and the fee waiver application. Applicants requesting a UCI Graduate Division fee waiver must submit their application 5 days prior to May 1, 2024, our program deadline.
PharmCAS and UCI Graduate Division have separate processes for requesting fee waivers. Each system may have different criteria, applicants may quality for a waiver in one system, but not the other. Visit PharmCAS Fee and Fee Waivers to learn more about eligibility criteria and fee waiver application.
Resources
PharmCAS 2023-2024 Application Manual
“As a first-year student pharmacist, the clinical research aspect of pharmacy was new to me. Through my participation in the ACCP Clinical Research Challenge, I have further discovered how diligence, mentorship, and most importantly, teamwork, are essential forces that drive growing students like ourselves towards success.”
Aiah Lee, Student Pharmacist, Class of 2025
Accreditation Status
The Pharm.D. program is in the process of accreditation with two required agencies, the Accreditation Council for Pharmacy Education (ACPE) and WASC Senior College and University Commission (WSCUC).
WASC Senior College and University Commission (WSCUC): Approved as of November 30, 2020
Accreditation Council for Pharmacy Education (ACPE): Candidate status approved as of June 30, 2022. The University of California, Irvine School of Pharmacy and Pharmaceutical Sciences’ Doctor of Pharmacy program has been granted Candidate status by the Accreditation Council for Pharmacy Education.
Once students have enrolled in a new program that is currently recognized by ACPE with Precandidate Status, such program may be granted Candidate Status by ACPE. The granting of Candidate Status denotes a developmental program that is expected to mature in accordance with stated plans by the time the first class has graduated. Granting of Candidate Status brings rights and privileges of Accredited status. Public disclosure by the program of the terms and conditions of Candidate Status is required (see paragraph 7, “Reference to Accreditation”). With respect to clarification of the meaning of Candidate status, graduates of a program so designed would, in the opinion of ACPE, have the same rights and privileges of those graduates from a fully accredited program. The Candidate status denotes a developmental program that is expected to mature in accord with stated plans within a defined time period. It should be underscored, however, that decisions concerning eligibility for licensure by examination or reciprocity reside with the respective state boards of pharmacy in accordance with their state statutes and administrative rules. Should Candidate status be awarded to a program, ACPE would, however, make its position known and make recommendations consistent with that position.
190 South LaSalle Street, Suite 2850, Chicago, Illinois 60603-3499, 312-644-3575; FAX 866-228-2631; website: www.acpe-accredit.org